Covid-19'S Lasting Misery

Total Page:16

File Type:pdf, Size:1020Kb

Covid-19'S Lasting Misery Feature MARCO DI LAURO/GETTY MARCO A person who has recovered from COVID-19 takes part in a rehabilitation programme in Genoa, Italy. Gholamrezanezhad says the overall rate of such intermediate-term lung damage is likely to be much lower — his best guess is that it is less than 10%. Nevertheless, given that 28.2 million people are known to have been infected so far, and that the lungs are COVID-19’S just one of the places that clinicians have detected damage, even that low percentage implies that hundreds of thousands of people are experiencing lasting health consequences. Doctors are now concerned that the pandemic will lead to a significant surge LASTING MISERY of people battling lasting illnesses and disabilities. Because the disease is so new, no Months after infection with SARS-CoV-2, some one knows yet what the long-term impacts people are still battling fatigue, lung damage and will be. Some of the damage is likely to be a side effect of intensive treatments such an array of other symptoms. By Michael Marshall as intubation, whereas other lingering problems could be caused by the virus itself. But preliminary studies and existing research into other coronaviruses suggest that the virus he lung scans were the first sign of team started tracking patients in January can injure multiple organs and cause some trouble. In the early weeks of the using computed tomography (CT) scanning surprising symptoms. coronavirus pandemic, clinical to study their lungs. They followed up on People with more severe infections might radiologist Ali Gholamrezanezhad 33 of them more than a month later, and their experience long-term damage not just in their began to notice that some people as-yet-unpublished data suggest that more lungs, but in their heart, immune system, who had cleared their COVID-19 than one-third had tissue death that has led brain and elsewhere. Evidence from previous infection still had distinct signs of to visible scars. The team plans to follow the coronavirus outbreaks, especially the severe damage. “Unfortunately, sometimes group for several years. acute respiratory syndrome (SARS) epidemic, Tthe scar never goes away,” he says. These patients are likely to represent suggests that these effects can last for years. Gholamrezanezhad, at the University of the worst-case scenario. Because most And although in some cases the most Southern California in Los Angeles, and his infected people do not end up in hospital, severe infections also cause the worst Nature | Vol 585 | 17 September 2020 | 339 ©2020 Spri nger Nature Li mited. All rights reserved. Feature Onset of 6 weeks after 12 weeks after COVID-19 discharge discharge G. WIDMANN, C. SCHWABL & A. LUGER/INNSBRUCK MEDICAL UNIV. & A. LUGER/INNSBRUCK C. SCHWABL G. WIDMANN, Lung scans from a 50-year-old show that damage from COVID-19 (red) can improve with time — but many patients have lasting symptoms. long-term impacts, even mild cases can have studies exploring lasting lung damage have immune system. Many other viruses are life-changing effects — notably a lingering been published. Gholamrezanezhad’s team thought to do this. “For a long time, it’s been malaise similar to chronic fatigue syndrome. analysed lung CT images of 919 patients from suggested that people who have been infected Many researchers are now launching published studies1, and found that the lower with measles are immunosuppressed in an follow-up studies of people who had been lobes of the lungs are the most frequently extended period and are vulnerable to other infected with SARS-CoV-2, the virus that causes damaged. The scans were riddled with opaque infections,” says Daniel Chertow, who studies COVID-19. Several of these focus on damage to patches that indicate inflammation, that might emerging pathogens at the National Institutes specific organs or systems; others plan to track make it difficult to breathe during sustained of Health Clinical Center in Bethesda, a range of effects. In the United Kingdom, the exercise. Visible damage normally reduced Maryland. “I’m not saying that would be the Post-Hospitalisation COVID-19 Study (PHOSP- after two weeks1. An Austrian study also found case for COVID, I’m just saying there’s a lot we COVID) aims to follow 10,000 patients for a that lung damage lessened with time: 88% of don’t know.” SARS, for instance, is known to year, analysing clinical factors such as blood participants had visible damage 6 weeks decrease immune-system activity by reducing tests and scans, and collecting data on after being discharged from hospital, but by the production of signalling molecules called biomarkers. A similar study of hundreds of 12 weeks, this number had fallen to 56% (see interferons4. people over 2 years launched in the United go.nature.com/3hiiopi). The virus can also have the opposite States at the end of July. Symptoms might take a long time to fade; a effect, causing parts of the immune system What they find will be crucial in treating study2 posted on the preprint server medRxiv to become overactive and trigger harmful those with lasting symptoms and trying to in August followed up on people who had been inflammation throughout the body. This is prevent new infections from lingering. “We hospitalized, and found that even a month well documented in the acute phase of the need clinical guidelines on what this care after being discharged, more than 70% were illness, and is implicated in some of the short- of survivors of COVID-19 should look like,” reporting shortness of breath and 13.5% were term impacts. For instance, it might explain says Nahid Bhadelia, an infectious-diseases still using oxygen at home. why a small number of children with COVID-19 clinician at Boston University School of Evidence from people infected with other develop widespread inflammation and organ Medicine in Massachusetts, who is setting up a coronaviruses suggests that the damage will problems. clinic to support people with COVID-19. “That linger for some. A study3 published in February This immune over-reaction can also can’t evolve until we quantify the problem.” recorded long-term lung harm from SARS, happen in adults with severe COVID-19, and which is caused by SARS-CoV-1. Between 2003 researchers want to know more about the Enduring effects and 2018, Peixun Zhang at Peking University knock-on effects after the virus has run its In the first few months of the pandemic, as People’s Hospital in Beijing and his colleagues course. “It seems there’s a lag there for it to get governments scrambled to stem the spread tracked the health of 71 people who had been hold of the person and then cause this severe by implementing lockdowns and hospitals hospitalized with SARS. Even after 15 years, inflammation,” says Adrienne Randolph, a struggled to cope with the tide of cases, most 4.6% still had visible lesions on their lungs, and senior associate in critical-care medicine at research focused on treating or preventing 38% had reduced diffusion capacity, meaning Boston Children’s Hospital. “But then the thing infection. that their lungs were poor at transferring is that, long term, when they recover, how long Doctors were well aware that viral oxygen into the blood and removing carbon does it take the immune system to settle back infections could lead to chronic illness, but dioxide from it. to normality?” exploring that was not a priority. “At the COVID-19 often strikes the lungs first, but it beginning, everything was acute, and now is not simply a respiratory disease, and in many Heart of the matter we’re recognizing that there may be more people, the lungs are not the worst-affected An over-reactive immune system can lead to problems,” says Helen Su, an immunologist at organ. In part, that’s because cells in many inflammation, and one particularly susceptible the National Institute of Allergy and Infectious different locations harbour the ACE2 receptor organ is the heart. During the acute phase of Diseases in Bethesda, Maryland. “There is a that is the virus’s major target, but also because COVID-19, about one-third of patients show definite need for long-term studies.” the infection can harm the immune system, cardiovascular symptoms, says Mao Chen, a The obvious place to check for long-term which pervades the whole body. cardiologist at Sichuan University in Chengdu, harm is in the lungs, because COVID-19 begins Some people who have recovered from China. “It’s absolutely one of the short-term as a respiratory infection. Few peer-reviewed COVID-19 could be left with a weakened consequences.” 340 | Nature | Vol 585 | 17 September 2020 ©2020 Spri nger Nature Li mited. All rights reserved. ©2020 Spri nger Nature Li mited. All rights reserved. One such symptom is cardiomyopathy, patients in China showed that 25% had those who ended up on ventilators, says in which the muscles of the heart become abnormal lung function after 3 months, and Chertow. In the worst cases, patients stretched, stiff or thickened, affecting the that 16% were still fatigued8. experience injury to muscles or the nerves heart’s ability to pump blood. Some patients Paul Garner, a infectious-disease researcher that supply them, and often face “a really also have pulmonary thrombosis, in which a at the Liverpool School of Tropical Medicine, long-fought battle on the order of months or clot blocks a blood vessel in the lungs. The UK, has experienced this at first hand. His up to years” to regain their previous health virus can also injure the wider circulatory initial symptoms were mild, but he has since and fitness, he says.
Recommended publications
  • 13.02.2020 Reference Type: Journal Article Record Number
    ► Day 14 – 13.02.2020 Reference Type: Journal Article Record Number: 689 Author: Ahmad, Tauseef, Khan, Muhammad, Khan, Fazal Mehmood and Hui, Jin Year: 2020 Title: Are we ready for the new fatal Coronavirus: scenario of Pakistan? Journal: Human Vaccines & Immunotherapeutics Pages: 1-3 Short Title: Are we ready for the new fatal Coronavirus: scenario of Pakistan? ISSN: 2164-5515 DOI: https://doi.org/10.1080/21645515.2020.1724000 Abstract: Scenario of Pakistan Pakistan, is the most affected countries, has experienced many diseases outbreaks and other disasters. Geographically and politically China and Pakistan are closely connected as shown in Figure 3. A large number of Chinese people are working in Pakistan on different developmental projects (China Pakistan Economic Corridor, Dams, Gawdar Port), and on the other hand many Pakistanis are residing in China carrying out their studies, business and jobs. The outbreak of coronavirus has appeared during the peak travel time when the Chinese from Pakistan and around the world are traveling to China, while the Pakistani community, especially students, are traveling back to Pakistan due to winter break. One of such case has been reported on 24 January 2020 after a person traveled from China to Pakistan on 21 January 2020 via Dubai and was diagnosed for 2019-nCoV on 24 January.3 However, the case was not notified officially by the government of Pakistan. In the depicted situation, the future is very alarming. After the ending of Chinese New Year celebrations, the Chinese will travel back to their jobs abroad, which may result in an outbreak of the fatal virus infection in Pakistan and other countries.
    [Show full text]
  • Strengthening Health Systems While Responding to a Health Crisis
    Strengthening Health Systems While Responding to a Health Crisis: Lessons Learned by a Nongovernmental Organization During the Ebola Virus Disease Epidemic in Sierra Leone The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Cancedda, C., S. M. Davis, K. L. Dierberg, J. Lascher, J. D. Kelly, M. B. Barrie, A. P. Koroma, et al. 2016. “Strengthening Health Systems While Responding to a Health Crisis: Lessons Learned by a Nongovernmental Organization During the Ebola Virus Disease Epidemic in Sierra Leone.” The Journal of Infectious Diseases 214 (Suppl 3): S153-S163. doi:10.1093/infdis/jiw345. http:// dx.doi.org/10.1093/infdis/jiw345. Published Version doi:10.1093/infdis/jiw345 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:29408366 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA The Journal of Infectious Diseases SUPPLEMENT ARTICLE Strengthening Health Systems While Responding to a Health Crisis: Lessons Learned by a Nongovernmental Organization During the Ebola Virus Disease Epidemic in Sierra Leone Corrado Cancedda,1,2,4 Sheila M. Davis,1 Kerry L. Dierberg,1,2 Jonathan Lascher,1 J. Daniel Kelly,2,7,10 Mohammed Bailor Barrie,1,4,10 Alimamy Philip Koroma,13 Peter George,15 Adikali Alpha Kamara,14 Ronald Marsh,11 Manso S. Sumbuya,12 Cameron T. Nutt,1,4 Kirstin W.
    [Show full text]
  • Strengthening Health Systems While Responding to a Health Crisis
    The Journal of Infectious Diseases SUPPLEMENT ARTICLE Strengthening Health Systems While Responding to a Health Crisis: Lessons Learned by a Nongovernmental Organization During the Ebola Virus Disease Epidemic in Sierra Leone Corrado Cancedda,1,2,4 Sheila M. Davis,1 Kerry L. Dierberg,1,2 Jonathan Lascher,1 J. Daniel Kelly,2,7,10 Mohammed Bailor Barrie,1,4,10 Alimamy Philip Koroma,13 Peter George,15 Adikali Alpha Kamara,14 Ronald Marsh,11 Manso S. Sumbuya,12 Cameron T. Nutt,1,4 Kirstin W. Scott,4 Edgar Thomas,1 Katherine Bollbach,1 Andrew Sesay,1,10 Ahmidu Barrie,1,10 Elizabeth Barrera,1 Kathryn Barron,1 John Welch,1,5 Nahid Bhadelia,1,6 Raphael G. Frankfurter,1,10 Ophelia M. Dahl,1 Sarthak Das,1 Rebecca E. Rollins,1 Bryan Eustis,1 Amanda Schwartz,1 Piero Pertile,1 Ilias Pavlopoulos,1 Allan Mayfield,1 Regan H. Marsh,1,3,4 Yusupha Dibba,1,10 Danielle Kloepper,1 Andrew Hall,1 Karin Huster,1,16 Michael Grady,1 Kimberly Spray,1 David A. Walton,1,2 Fodei Daboh,1,10 Cora Nally,1 Sahr James,1,10 Gabriel S. Warren,1 Joyce Chang,1 Michael Drasher,1 Gina Lamin,1,10 Sherry Bangura,1,10 Ann C. Miller,4 Annie P. Michaelis,1 Ryan McBain,1 M. Jana Broadhurst,1 Megan Murray,1,2,4 Eugene T. Richardson,1,2,8,9 Ted Philip,1 Gary L. Gottlieb,1 Joia S. Mukherjee,1,2,4 and Paul E. Farmer1,2,4 1Partners In Health, 2Division of Global Health Equity, and 3Department of Emergency Medicine, Brigham and Women’s Hospital, 4Department of Global Health and Social Medicine, Harvard Medical School, 5Department of Anesthesiology, Perioperative, and Pain Medicine, Boston
    [Show full text]
  • World View by Nahid Bhadelia Coronavirus: Hospitals Must Learn from Past Pandemics
    A personal take on science and society World view By Nahid Bhadelia Coronavirus: hospitals must learn from past pandemics Use methods honed in previous outbreaks to and separating them from others with similar symptoms. prepare for the next one, says Nahid Bhadelia. Countries with confirmed cases are sharing viral genetic What do sequences — which makes developing tests easier. Many hospitals in richer countries must decide whether he world that is grappling with 2019 novel you do patients should be cared for in specialized biocontain- coronavirus (2019-nCoV) is different from how when large ment units created for people with Ebola virus disease or it was during the SARS and H1N1 pandemics. numbers of in rooms assigned to those with other airborne diseases, The disease itself, and information and disin- such as tuberculosis and measles. But the demand for both formation, now travel faster than ever. people arrive could soon outstrip supply if the epidemic spreads, so hos- TI worked as a clinician in West Africa during the Ebola at facilities pitals could create a stepwise plan: one for dealing with a outbreak, and in New York City hospitals during the H1N1 with an handful of patients, and another for when large numbers of one. Now, I’m working in Boston, Massachusetts, to prepare sick patients cause a shortage of intensive-care beds. Hos- for potential cases of 2019-nCoV acute respiratory disease. unfamiliar pitals might need to work with nearby facilities to ensure And many of the challenges are the same as those faced in disease?” every person needing intensive care receives it.
    [Show full text]
  • FY15 NEIDL Annual Report
    Annual Report , 2015 Blank page September 1, 2015 Letter from the Director This is the first annual report since the NEIDL Institute officially became a University Center on October 01, 2014. With this transition, the NEIDL changed its reporting structure from the Dean of the School of Medicine to the Associate Provost and Vice President for Research of Boston University. This change is important for two reasons. First, the change in reporting recognizes the significance of the current and future investments made by the University into the NEIDL, and for the field of emerging infectious diseases, as a focal point of research for the University. Second, it underscores the importance of embracing the breadth of research within in the University into the NEIDL as we recruit faculty. The study of emerging infectious diseases is by its very nature interdisciplinary, and leveraging expertise via joint recruitments with departments across the university will ensure a robust and innovative research portfolio necessary for the future success of the Institute. This diversity of expertise will be an important differentiator for the NEIDL. Coincident with the change, I had the privilege of being appointed as Director of the NEIDL. I do not take this responsibility lightly. With it comes not only the responsibility for establishing the scientific vision for the foreseeable future, together with many stakeholders across Boston University, but to also continue fostering the culture of safety in all that we do. We also have the responsibility to the public to be completely transparent in what we do. Public trust is essential to the future success of the NEIDL.
    [Show full text]
  • The Truth About Ebola for New England: Fact Vs. Hype Friday, November 7, 2014 Boston University's National Emerging Infectious
    The Truth About Ebola for New England: Fact vs. Hype Friday, November 7, 2014 Boston University’s National Emerging Infectious Diseases Laboratories Program Agenda 9:30 – 10:00 Check-in/Networking/Coffee 10:00 – 10:20 Introductory Remarks Dr. Robert Brown, President Boston University James T. Brett, President & CEO The New England Council Cheryl Bartlett, Commissioner Massachusetts Department of Public Health 10:20 -11:20 Moderated Panel Discussion Moderator: James T. Brett, President & CEO The New England Council Panelists: Dr. Nahid Bhadelia, M.D. - Director of Infection Control, Boston University National Emerging Infectious Diseases Laboratories Dr. Paul D. Biddinger, M.D. – Director of Operations for Emergency Medicine and Medical Director for Emergency Preparedness, Massachusetts General Hospital Dr. Jamie Childs, Sc.D. – Senior Research Scientist & Lecturer in Epidemiology, Yale School of Public Health Dr. Ronald B. Corley, Ph.D. – Director, Boston University National Emerging Infectious Diseases Laboratories 11:20 – 12:00 Audience Q&A Panelist Biographies Dr. Nahid Bhadelia, M.D. Director of Infection Control Boston University National Emerging Infectious Diseases Laboratories Dr. Bhadelia is an Assistant Professor of Medicine in the Section of Infectious Diseases and the Associate Hospital Epidemiologist at Boston Medical Center. She is also the Director of Infection Control at National Emerging Infectious Diseases Laboratories (NEIDL) at Boston University. Her specialization is with in infection control issues related to emerging pathogens and highly communicable infectious diseases. She is the director of the medical response program for BU’s biosafety level 4 laboratories at the NEIDL and provides input into BU’s Research Occupational Health policies related to infectious diseases.
    [Show full text]
  • July 9, 2021 the Honorable Patty Murray Chair, Committee on Health
    Boston University Center for Emerging Infectious Diseases Policy & Research 620 Albany Street Boston, Massachusetts 02118 T 617-358-9192 [email protected] July 9, 2021 The Honorable Patty Murray Chair, Committee on Health, Education, Labor, and Pensions United States Senate Washington, DC 20510 The Honorable Richard Burr Ranking Member, Committee on Health, Education, Labor, and Pensions United States Senate Washington, DC 20510 Dear Chairwoman Murray and Ranking Member Burr: We at Boston University’s (BU) Center for Emerging Infectious Diseases Policy and Research (CEID) strongly support your efforts to improve the nation’s public health and medical PreParedness and resPonse Programs in the wake of the COVID-19 Pandemic. We apPreciate the oPPortunity to provide input on these critical toPics. CEID’s core mission is to improve resilience against the threat of emerging & epidemic infectious diseases worldwide through transdisciPlinary research, global and local capacity strengthening, training, generating evidence for policy suPPort, and community engagement. Alongside our sister institute, National Emerging Infectious Diseases Laboratories (NEIDL), BU’s maximum containment research Program, we work to improve global resPonse to these threats. CEID’s faculty bring decades of exPerience resPonding on the frontline of emerging infectious outbreaks, running biocontainment Patient care units, leading national sPecial Pathogens research networks, codirecting Geosentinel Surveillance Network, running national and international public health and Pandemic
    [Show full text]
  • FY16 NEIDL Annual Report
    Annual Report Fiscal Year 2016 Table of Contents Letter from the Director …………………………………………………………….………………………………………………...................... 1 3 Mission and Strategic Plan …………………………………………………………….………………………………….………………………..…… Faculty and Staff………………………………………………………………….…………………………………………………………................... 4 Scientific Leadership ……………………………………………….……………………………………………………………................ 4 Principal Investigators………………………………………………………………..…………………………………………................ 4 Researchers and Laboratory Staff………………………………………..………………………………………………................. 6 Students……………………………………………………………………………………………………………………………….................. 7 Animal Research Support………………………………………………………………………………………………………................ 8 Operations Leadership…………………………………………………………………………………………………………................ 8 Administration ……………………………………………………………………………………………………………………................ 8 Community Relations……………………………………………………………………….…………………………………................. 9 Facilities Maintenance and Operations……………………………………………………….………………………................. 9 Environmental Health & Safety ………………………………………………………………………………………….................. 9 Public Safety………………………………………………………………………………………………………….…………….................. 9 Research…………………………………………………………………………………………………………………….………………………................ 11 Publications …………………………………………………………………………………….……………………………................……. 11 Y16 Funded Research………………………………………………………………………..……………..……………………………….................. 15 Seed Funding………………………………………………………………………………………………………….……………................ 18 NEIDL Faculty Recognition
    [Show full text]
  • Microsoft Outlook
    Chris Taggart From: James R Olsen <[email protected]> Sent: Sunday, March 29, 2020 9:53 AM To: James Olsen Subject: Input On COVID - 19 THE ATLANTIC MAGAZINE HEALTH How the Pandemic Will End The U.S. may end up with the worst COVID-19 outbreak in the industrialized world. This is how it’s going to play out. ED YONG, Mar 25, 2020 Editors Note: The Atlantic is making vital coverage of the coronavirus available to all readers. Find the collection here. Three months ago, no one knew that SARS-CoV-2 existed. Now the virus has spread to almost every country, infecting at least 446,000 people whom we know about, and many more whom we do not. It has crashed economies and broken health-care systems, filled hospitals and emptied public spaces. It has separated people from their workplaces and their friends. It has disrupted modern society on a scale that most living people have never witnessed. Soon, most everyone in the United States will know someone who has been infected. Like World War II or the 9/11 attacks, this pandemic has already imprinted itself upon the nation’s psyche. A global pandemic of this scale was inevitable. In recent years, hundreds of health experts have written books, white papers, and op-eds warning of the possibility. Bill Gates has been telling anyone who would listen, including the 18 million viewers of his TED Talk. In 2018, I wrote a story for The Atlantic arguing that America was not ready for the pandemic that would eventually come.
    [Show full text]
  • Background Paper
    BACKGROUND PAPER Henry J. Leir Institute • The Fletcher School of Law and Diplomacy • Tufts University • (617) 627-0992 • bit.ly/LeirInstitute JUNE 2019 Henry J. Leir Institute Infectious Disease: The Henry J. Leir Institute at The Fletcher School, Tufts University focuses on the security and protection of individuals and Stigmatization of Refugees communities while promoting peace and sustainable development. To achieve this, the Leir Institute catalyzes collaboration and Vulnerable Migrants between and creates synergies among the fields that place people at the center of concern: conflict resolution, human rights, Geneva Workshop humanitarian studies, and political and economic development. Our research, Tuesday, 27 November 2018 education, and policy engagement emphasize the following principles: protection and promotion of the rights of at- risk populations, empowerment of people, There are approximately 250 million migrants in the world today. Twenty-eight mil- and promotion of responsible government lion of those are refugees and asylum seekers. In addition, an untold number have and institutional practices. been forcibly displaced or are in vulnerable situations yet lack refugee status. This For more information on the research mass movement of people has prompted global public discourse about the rights project, please contact Ian.Johnstone@ of people fleeing danger or persecution and the responsibilities (or limits thereof) tufts.edu or [email protected]. of countries willing to accept them. Many national governments and international DR. NAHID BHADELIA organizations face a complex public health and programmatic quandary of how to Assistant Professor, Boston Universi- meet the health needs of these vulnerable populations and assess the risk to the ty School of Medicine and Director of health of host communities, while not stoking further fear and stigmatization.
    [Show full text]
  • United States Court of Appeals Second Circuit
    Case 17-1558, Document 67, 07/12/2017, 2077483, Page1 of 42 17-1558-cv United States Court of Appeals for the Second Circuit LIBERIAN COMMUNITY ASSOCIATION OF CONNECTICUT, on behalf of themselves and those similarly situated, LOUISE MENSAH-SIEH, on behalf of herself and her minor children B.D. and S.N., on behalf of themselves and those similarly situated, VICTOR SIEH, on behalf of themselves and those similarly situated, EMMANUEL KAMARA, on behalf of themselves and those similarly situated, ASSUNTA NIMLEY-PHILLIPS, on behalf of themselves and those similarly situated, LAURA SKRIP, on behalf of themselves and those similarly situated, RYAN BOYKO, on behalf of themselves and those similarly situated, ESTHER YALARTAI, on behalf of themselves and those similarly situated, BISHOP HARMON YALARTAI, on behalf of themselves and those similarly situated, MARY JEAN O, on behalf of themselves and those similarly situated, Plaintiffs-Appellants, NATHANIEL SIEH, on behalf of themselves and those similarly situated. Plaintiff, (For Continuation of Caption See Inside Cover) –––––––––––––––––––––––––––––– ON APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF CONNECTICUT BRIEF FOR AMICI CURIAE MARK BARNES AND LEANA WEN IN SUPPORT OF APPELLANTS DAVID A. BARRETT ANN O’LEARY KATHLEEN HARTNETT YOTAM BARKAI BOIES SCHILLER FLEXNER LLP Attorneys for Amici Curiae Mark Barnes and Leana Wen 575 Lexington Avenue New York, New York 10022 (212) 446-2300 Case 17-1558, Document 67, 07/12/2017, 2077483, Page2 of 42 – v. – DANNEL P. MALLOY, Governor, RAUL PINO, Commissioner of Public Health, JEWEL MULLEN, Former Commissioner of Public Health, Defendants-Appellees. Case 17-1558, Document 67, 07/12/2017, 2077483, Page3 of 42 TABLE OF CONTENTS TABLE OF AUTHORITIES ..................................................................................
    [Show full text]
  • IMANE Annual Meeting Brochure
    Message from the President Seema Arora, MD It is rightly said that the We also provided free health screenings to a large number of “Journey is Equally as community people at our booth at 'India Independence Day Important as the Destination!” Celebrations' at the Hatch shell in Boston. We conducted Bone Marrow Drives this year in collaboration with South Asian th My journey as the 37 President organization SAMAR. We also teamed up with United India st of IMANE started on Jan 1 Association of New England to participate in a 'Breast Cancer st 2015 and will end on Dec 31 Awareness Walk' organized by the American Cancer Society 2015. For me, it has been a and contributed our donations. We have continued our involvement year of enormous learning, in many IMANE charitable and community service projects tremendous personal growth including our Free Health Clinics in Shrewsbury and Worcester and great achievements. Like where our physicians have been providing their voluntary services. any other journey, it has had Besides our own charitable projects, IMANE also contributed its ups and downs but overall through supporting charities and fundraisers of other organizations it has been a very pleasurable in the community like SAHELI, Project MANSI, Pakistani experience for me and a very Association, AFMI, etc. productive year for IMANE. Working together with my ‘Awesome Team of 2015', we were able to achieve all the goals that I had set Every President comes with dreams and aspirations to forth in the beginning of the year which makes me leave office contribute to the organization through their unique strengths.
    [Show full text]